Literature DB >> 8312142

Pityriasis versicolor.

J Faergemann1.   

Abstract

The lipophilic yeast Pityrosporum ovale is both a member of the normal human cutaneous flora in adults and the etiological agent of pityriasis versicolor. Pityriasis versicolor develops under the influence of predisposing factors. The presence of these factors are also the reason for the high rate of recurrence seen in pityriasis versicolor and for its chronicity. There are numerous ways of treating pityriasis versicolor topically and systemically. Propylene glycol 50% in water is effective and cheap, but the imidazoles and the older antidandruff shampoos as well as two new antifungals: ciclopiroxolamine and terbinafine are also effective topically. However, short-term oral treatment with ketoconazole, itraconazole or fluconazole are very effective and the risk for side effects minimized with short treatment regiments. The patient compliance is also higher with oral treatment. The recurrence rate is very high, and to avoid this a prophylactic treatment schedule (eg, ketoconazole) one 200 mg tablet on three consecutive days every month or a single dose of 400 mg every month are effective.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8312142

Source DB:  PubMed          Journal:  Semin Dermatol        ISSN: 0278-145X


  5 in total

Review 1.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Study of the Distribution of Malassezia Species in Patients with Pityriasis Versicolor in Kolar Region, Karnataka.

Authors:  Banur Raju Archana; Paravangada Madappa Beena; Shiva Kumar
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

3.  Clinical and epidemiological features of the genus Malassezia in Iran.

Authors:  Elham Zeinali; Golnar Sadeghi; Fahimeh Yazdinia; Masoomeh Shams-Ghahfarokhi; Mehdi Razzaghi-Abyaneh
Journal:  Iran J Microbiol       Date:  2014-10

4.  SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL.

Authors:  Daiane Heidrich; Tatiane Caroline Daboit; Cheila Denise Ottonelli Stopiglia; Cibele Massotti Magagnin; Gerson Vetoratto; Taís Guarienti Amaro; Maria Lúcia Scroferneker
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

5.  Randomized comparative clinical trial of Artemisia sieberi 5% lotion and clotrimazole 1% lotion for the treatment of pityriasis versicolor.

Authors:  Farrokh Rad; Farzad Aala; Naser Reshadmanesh; Rokshana Yaghmaie
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.